These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
538 related items for PubMed ID: 10193877
1. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Näslund E, Barkeling B, King N, Gutniak M, Blundell JE, Holst JJ, Rössner S, Hellström PM. Int J Obes Relat Metab Disord; 1999 Mar; 23(3):304-11. PubMed ID: 10193877 [Abstract] [Full Text] [Related]
2. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Flint A, Raben A, Ersbøll AK, Holst JJ, Astrup A. Int J Obes Relat Metab Disord; 2001 Jun; 25(6):781-92. PubMed ID: 11439290 [Abstract] [Full Text] [Related]
3. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. Toft-Nielsen MB, Madsbad S, Holst JJ. Diabetes Care; 1999 Jul; 22(7):1137-43. PubMed ID: 10388979 [Abstract] [Full Text] [Related]
4. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. Flint A, Raben A, Astrup A, Holst JJ. J Clin Invest; 1998 Feb 01; 101(3):515-20. PubMed ID: 9449682 [Abstract] [Full Text] [Related]
5. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Näslund E, Gutniak M, Skogar S, Rössner S, Hellström PM. Am J Clin Nutr; 1998 Sep 01; 68(3):525-30. PubMed ID: 9734726 [Abstract] [Full Text] [Related]
6. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Gutzwiller JP, Drewe J, Göke B, Schmidt H, Rohrer B, Lareida J, Beglinger C. Am J Physiol; 1999 May 01; 276(5):R1541-4. PubMed ID: 10233049 [Abstract] [Full Text] [Related]
11. Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men. Steinert RE, Schirra J, Meyer-Gerspach AC, Kienle P, Fischer H, Schulte F, Goeke B, Beglinger C. Am J Clin Nutr; 2014 Aug 01; 100(2):514-23. PubMed ID: 24965303 [Abstract] [Full Text] [Related]
12. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. Verdich C, Flint A, Gutzwiller JP, Näslund E, Beglinger C, Hellström PM, Long SJ, Morgan LM, Holst JJ, Astrup A. J Clin Endocrinol Metab; 2001 Sep 01; 86(9):4382-9. PubMed ID: 11549680 [Abstract] [Full Text] [Related]
19. The capsaicin analog nonivamide decreases total energy intake from a standardized breakfast and enhances plasma serotonin levels in moderately overweight men after administered in an oral glucose tolerance test: a randomized, crossover trial. Hochkogler CM, Rohm B, Hojdar K, Pignitter M, Widder S, Ley JP, Krammer GE, Somoza V. Mol Nutr Food Res; 2014 Jun 15; 58(6):1282-90. PubMed ID: 24753478 [Abstract] [Full Text] [Related]
20. Effect of gender on the acute effects of whey protein ingestion on energy intake, appetite, gastric emptying and gut hormone responses in healthy young adults. Giezenaar C, Luscombe-Marsh ND, Hutchison AT, Lange K, Hausken T, Jones KL, Horowitz M, Chapman I, Soenen S. Nutr Diabetes; 2018 Jul 13; 8(1):40. PubMed ID: 30006513 [Abstract] [Full Text] [Related] Page: [Next] [New Search]